Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
110.10
-5.35 (-4.63%)
At close: Nov 16, 2026
BOM:524412 Revenue
Aarey Drugs & Pharmaceuticals had revenue of 902.43M INR in the quarter ending September 30, 2026, with 7.23% growth. This brings the company's total for the last twelve months to 4.20B, down -1.90% year-over-year. In the fiscal year ending March 31, 2026, Aarey Drugs & Pharmaceuticals had annual revenue of 4.72B, down -0.35%. That makes Aarey Drugs & Pharmaceuticals the 28,798th largest company in the world by revenue and 1,952nd in India.
Revenue (ttm)
4.20B
Revenue Growth
-1.90%
P/S Ratio
0.75
Revenue / Employee
31.83M
Employees
132
Market Cap
3.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.72B | -16.74M | -0.35% |
| Mar 31, 2025 | 4.74B | 713.61M | 17.73% |
| Mar 31, 2024 | 4.03B | -163.73M | -3.91% |
| Mar 31, 2023 | 4.19B | -739.78M | -15.01% |
| Mar 31, 2022 | 4.93B | 1.42B | 40.27% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Influx Healthtech | 1.65B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.10B |
| Kimia Biosciences | 1.04B |
| Shree Ganesh Remedies | 919.58M |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |